Home LiteratureArticle Details
PMID: 1396923 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

The respiratory syncitial virus and its role in acute bronchiolitis.

European journal of pediatrics ·Vol. 151 ·No. 9 ·1992-09-00 ·Pages 638-51

Everard ML, Milner AD

Abstract

暂无摘要

MeSH Terms
Acute Disease Animals Antibodies, Viral Blood Platelets/immunology Bronchiolitis, Viral/immunology,microbiology,therapy Humans Immunoglobulin E/immunology Immunoglobulin G/immunology Monocytes/immunology Neutrophils/immunology Platelet Membrane Glycoproteins/immunology Respiratory Syncytial Viruses/immunology Respirovirus Infections/complications,immunology,therapy Ribavirin/therapeutic use T-Lymphocytes, Cytotoxic/immunology Thrombospondins Viral Vaccines
Chemicals
Antibodies, Viral Immunoglobulin G Platelet Membrane Glycoproteins Thrombospondins Viral Vaccines Immunoglobulin E Ribavirin
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Everard M L
Department of Child Health, Queens Medical Centre, Nottingham, UK.
Milner A D
References (205)
205 references, click to expand
  1. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection.
    J Gen Virol. 1983 Sep;64 (Pt 9):1867-76 PMID: 6886679
  2. Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage.
    J Immunol. 1985 Mar;134(3):1493-7 PMID: 3918100
  3. Lung function and bronchial responsiveness in children who had infantile bronchiolitis.
    Pediatr Pulmonol. 1987 Jan-Feb;3(1):38-44 PMID: 3588049
  4. Deficiency of immune interferon production by leukocytes of normal newborns.
    Cell Immunol. 1980 Sep 15;55(1):191-200 PMID: 6159105
  5. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine.
    Am J Epidemiol. 1969 Apr;89(4):422-34 PMID: 4305198
  6. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.
    N Engl J Med. 1988 Oct 27;319(17):1112-7 PMID: 3173442
  7. Viral receptors of the immunoglobulin superfamily.
    Cell. 1989 Mar 10;56(5):725-8 PMID: 2538240
  8. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages.
    Am Rev Respir Dis. 1989 Sep;140(3):771-7 PMID: 2476959
  9. Respiratory syncytial viral infection in children with compromised immune function.
    N Engl J Med. 1986 Jul 10;315(2):77-81 PMID: 3724802
  10. Respiratory syncytial virus envelope glycoprotein (G) has a novel structure.
    Nucleic Acids Res. 1985 Nov 11;13(21):7795-812 PMID: 4069997
  11. Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus.
    Prog Med Virol. 1980;26:94-118 PMID: 6999535
  12. Defective IFN-gamma production in the human neonate. II. Role of increased sensitivity to the suppressive effects of prostaglandin E.
    J Immunol. 1985 Jan;134(1):172-6 PMID: 2981090
  13. Ribavirin: adverse drug reactions, 1986 to 1988.
    Pediatr Infect Dis J. 1990 Mar;9(3):209-11 PMID: 2139930
  14. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice.
    J Pediatr. 1979 Aug;95(2):183-90 PMID: 448557
  15. Defective regulation of immune responses in respiratory syncytial virus infection.
    J Immunol. 1984 Oct;133(4):1925-30 PMID: 6236259
  16. Precautions in the use of ribavirin at the children's hospital.
    N Engl J Med. 1990 Mar 1;322(9):634 PMID: 2304514
  17. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo.
    J Infect Dis. 1985 Nov;152(5):895-902 PMID: 2931491
  18. Acute fatal pneumonia in calves due to respiratory syncytial virus.
    Vet Rec. 1981 May 9;108(19):411-6 PMID: 7257127
  19. Monoclonal antibodies protect against respiratory syncytial virus.
    Lancet. 1983 Oct 22;2(8356):976 PMID: 6138541
  20. Respiratory failure and mechanical ventilation in severe bronchiolitis.
    Arch Dis Child. 1989 Oct;64(10):1431-7 PMID: 2684031
  21. Atopy does not predispose to RSV bronchiolitis or postbronchiolitic wheezing.
    Br Med J (Clin Res Ed). 1981 Jun 27;282(6282):2086-8 PMID: 6788213
  22. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response.
    Pediatr Res. 1985 May;19(5):420-4 PMID: 4000767
  23. Continuing respiratory problems three and a half years after acute viral bronchiolitis.
    Arch Dis Child. 1985 Nov;60(11):1064-7 PMID: 4073937
  24. Prostaglandin and thromboxane concentrations in plasma and lung lavage fluids during sequential infection of vaccinated and nonvaccinated calves with bovine respiratory syncytial virus.
    Am J Vet Res. 1989 Aug;50(8):1254-62 PMID: 2782709
  25. Influence of immunological factors in respiratory syncytial virus disease.
    Arch Environ Health. 1970 Sep;21(3):347-55 PMID: 4323368
  26. Immunoglobulins in tracheo-bronchial secretion with special reference to IgE.
    Clin Exp Immunol. 1974 Mar;16(3):401-12 PMID: 4468847
  27. Interferon and respiratory syncytial virus.
    Lancet. 1970 Mar 14;1(7646):574-5 PMID: 4190538
  28. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection.
    J Clin Microbiol. 1986 Nov;24(5):894-8 PMID: 3771779
  29. Bronchiolitis.
    Am J Dis Child. 1983 Aug;137(8):805-6 PMID: 6869345
  30. Respiratory syncytial virus infections within families.
    N Engl J Med. 1976 Feb 19;294(8):414-9 PMID: 173995
  31. Interferon production in adults with respiratory syncytial viral infection.
    Ann Intern Med. 1981 Jan;94(1):53-5 PMID: 6160798
  32. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis.
    J Pediatr. 1986 Nov;109(5):776-80 PMID: 3772657
  33. Immunoglobulin G subclass proteins in serum and lavage fluid of normal subjects. Quantitation and comparison with immunoglobulins A and E.
    Am Rev Respir Dis. 1985 Apr;131(4):584-7 PMID: 3994153
  34. Characterization of prolonged apneic episodes associated with respiratory syncytial virus infection.
    Pediatr Pulmonol. 1989;6(3):195-201 PMID: 2717245
  35. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children.
    Pediatrics. 1973 Jul;52(1):56-63 PMID: 4353352
  36. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine.
    Am J Epidemiol. 1969 Apr;89(4):405-21 PMID: 4305197
  37. Production of interferon in respiratory syncytial virus bronchiolitis.
    Arch Dis Child. 1989 Jan;64(1):92-5 PMID: 2923479
  38. Cellular and humoral immunity in recurrent respiratory syncytial virus infections.
    Pediatr Res. 1983 Sep;17(9):753-8 PMID: 6622111
  39. Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection.
    J Clin Microbiol. 1989 Feb;27(2):295-9 PMID: 2915022
  40. Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic.
    Pediatr Infect Dis J. 1987 Feb;6(2):152-8 PMID: 3562136
  41. IgG subclasses: development of the serum concentrations in "normal" infants and children.
    J Pediatr. 1972 Jun;80(6):960-4 PMID: 4623683
  42. Respiratory syncytial viral infection in infants with congenital heart disease.
    N Engl J Med. 1982 Aug 12;307(7):397-400 PMID: 7088112
  43. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.
    Lancet. 1987 Oct 3;2(8562):769-71 PMID: 2888988
  44. Phagocytic cell-derived inflammatory mediators and lung disease.
    Chest. 1987 Mar;91(3):428-35 PMID: 3102174
  45. The role of neutrophils in the pathogenesis of rhinovirus infections.
    Pediatr Infect Dis J. 1990 Nov;9(11):832-5 PMID: 2175875
  46. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection.
    J Clin Microbiol. 1986 Jun;23(6):1009-14 PMID: 3754878
  47. Effect of salbutamol on respiratory mechanics in bronchiolitis.
    Pediatr Res. 1987 Jul;22(1):83-6 PMID: 3627878
  48. Ribavirin aerosol for acute bronchiolitis.
    Arch Dis Child. 1986 Jun;61(6):593-7 PMID: 3524473
  49. Respiratory syncytial virus infection of the newborn.
    Br Med J. 1970 Jul 18;3(5715):146-7 PMID: 4914436
  50. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.
    J Immunol. 1988 May 15;140(10):3473-81 PMID: 3258884
  51. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants.
    Pediatrics. 1983 Nov;72(5):613-8 PMID: 6356005
  52. Childhood asthma following hospitalization with acute viral bronchiolitis in infancy.
    Pediatr Pulmonol. 1989;7(3):153-8 PMID: 2797929
  53. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection.
    J Med Virol. 1989 Jul;28(3):133-9 PMID: 2666570
  54. Interferon in lungs.
    Lancet. 1989 Jun 10;1(8650):1333 PMID: 2566863
  55. Respiratory syncytial virus-related apnea in infants. Demographics and outcome.
    Am J Dis Child. 1984 Mar;138(3):247-50 PMID: 6702769
  56. In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera.
    J Gen Virol. 1989 Jan;70 ( Pt 1):89-96 PMID: 2732688
  57. Modes of transmission of respiratory syncytial virus.
    J Pediatr. 1981 Jul;99(1):100-3 PMID: 7252646
  58. Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children.
    Am J Dis Child. 1969 May;117(5):495-503 PMID: 4889355
  59. Detection by ELISA of IgG-subclass-specific antibodies in primary respiratory syncytial (RS) virus infections.
    J Med Virol. 1985 Aug;16(4):321-8 PMID: 3897452
  60. Role of IgE in the pathogenesis of bovine respiratory syncytial virus in sequential infections in vaccinated and nonvaccinated calves.
    Am J Vet Res. 1989 Mar;50(3):349-55 PMID: 2930022
  61. Long-term prospective study in children after respiratory syncytial virus infection.
    J Pediatr. 1984 Sep;105(3):358-64 PMID: 6470859
  62. Detection of respiratory syncytial virus in clinical specimens by viral culture, direct and indirect immunofluorescence, and enzyme immunoassay.
    J Clin Microbiol. 1988 Mar;26(3):588-91 PMID: 3281981
  63. Increases in plasma concentrations of a prostaglandin metabolite in acute airway obstruction.
    Arch Dis Child. 1989 Aug;64(8):1112-7 PMID: 2641987
  64. Risk of primary infection and reinfection with respiratory syncytial virus.
    Am J Dis Child. 1986 Jun;140(6):543-6 PMID: 3706232
  65. Cell-mediated immunity in respiratory syncytial virus disease.
    J Med Virol. 1984;13(1):105-14 PMID: 6693860
  66. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.
    Antimicrob Agents Chemother. 1987 Dec;31(12):1882-6 PMID: 3439796
  67. Chest physiotherapy in acute bronchiolitis.
    Arch Dis Child. 1985 Nov;60(11):1078-9 PMID: 3907510
  68. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.
    JAMA. 1985 Dec 6;254(21):3047-51 PMID: 3903239
  69. Respiratory syncytial virus infection: admissions to hospital in industrial, urban, and rural areas. Report to the Medical Research Council Subcommittee on Respiratory Syncytial Virus Vaccines.
    Br Med J. 1978 Sep 16;2(6140):796-8 PMID: 359099
  70. Immunoglobulin subclasses in normal children.
    Pediatr Res. 1979 Mar;13(3):181-3 PMID: 471573
  71. Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: evidence for the involvement of complement and mast cell mediators.
    Am J Vet Res. 1989 May;50(5):694-700 PMID: 2786355
  72. Respiratory syncytial virus infections in infants: quantitation and duration of shedding.
    J Pediatr. 1976 Jul;89(1):11-5 PMID: 180274
  73. Ineffectiveness of ipratropium bromide in acute bronchiolitis.
    Arch Dis Child. 1983 Nov;58(11):925-6 PMID: 6228197
  74. Immunoglobulin E in bronchiolitis.
    Pediatrics. 1972 Aug;50(2):279-84 PMID: 5065211
  75. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.
    J Infect Dis. 1985 Apr;151(4):626-33 PMID: 2579169
  76. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease.
    N Engl J Med. 1970 Jun 4;282(23):1283-7 PMID: 5442359
  77. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants.
    Clin Exp Immunol. 1985 Feb;59(2):505-11 PMID: 3919982
  78. Effect of bronchodilators on respiratory resistance in infants and young children with bronchiolitis and wheezy bronchitis.
    Arch Dis Child. 1975 Sep;50(9):719-22 PMID: 1190821
  79. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in north-east England.
    Lancet. 1978 Nov 11;2(8098):1035-8 PMID: 82045
  80. Seasonal pattern in childhood viral lower respiratory tract infections in Melbourne.
    Med J Aust. 1980 Jan 12;1(1):22-4 PMID: 6244480
  81. Respiratory virus infection of peripheral blood monocytes: correlation with ageing of cells and interferon production in vitro.
    J Gen Virol. 1987 Jun;68 ( Pt 6):1749-53 PMID: 3035067
  82. Application of immunofluorescent antibody technique in rapid diagnosis of respiratory syncytial virus infection.
    Br Med J. 1968 Aug 10;3(5614):340-3 PMID: 4173963
  83. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.
    N Engl J Med. 1983 Jun 16;308(24):1443-7 PMID: 6343860
  84. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.
    Am J Epidemiol. 1969 Apr;89(4):435-48 PMID: 4305199
  85. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.
    Nature. 1989 May 4;339(6219):64-7 PMID: 2469965
  86. Sympathomimetic drugs in acute viral bronchiolitis. Their effect on pulmonary resistance.
    Pediatrics. 1969 Oct;44(4):493-7 PMID: 5346627
  87. THE TREATMENT OF BRONCHIOLITIS.
    J Pediatr. 1963 Dec;63:1205-7 PMID: 14089830
  88. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.
    Ann Intern Med. 1978 Feb;88(2):203-5 PMID: 415653
  89. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2.
    Proc Natl Acad Sci U S A. 1988 Sep;85(18):6880-4 PMID: 2970644
  90. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.
    J Infect Dis. 1982 Mar;145(3):311-9 PMID: 7037983
  91. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.
    J Pediatr. 1981 May;98(5):708-15 PMID: 7229749
  92. Pathogenesis of naturally acquired bovine respiratory syncytial virus infection in calves: morphologic and serologic findings.
    Am J Vet Res. 1989 May;50(5):684-93 PMID: 2729714
  93. Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus.
    Am J Dis Child. 1979 Aug;133(8):798-802 PMID: 463835
  94. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses.
    J Virol. 1988 Oct;62(10):3907-10 PMID: 3047432
  95. Neutrophils and antiviral defense.
    Pediatr Infect Dis. 1986 Jan-Feb;5(1):86-92 PMID: 3511457
  96. Comparative virulence of respiratory syncytial virus subgroups A and B.
    Lancet. 1989 Apr 8;1(8641):777-8 PMID: 2564579
  97. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    J Immunol. 1988 Aug 15;141(4):1218-24 PMID: 3135324
  98. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies.
    J Clin Invest. 1986 Mar;77(3):860-7 PMID: 3081575
  99. Macrophages and polymorphonuclear neutrophils in lung defense and injury.
    Am Rev Respir Dis. 1990 Feb;141(2):471-501 PMID: 2405761
  100. Clinical observations on mechanical ventilation for respiratory failure in bronchiolitis.
    Pediatr Pulmonol. 1986 Sep-Oct;2(5):307-11 PMID: 3022224
  101. IgG subclass levels in infancy and childhood.
    Acta Paediatr Scand. 1979 Jan;68(1):23-7 PMID: 758727
  102. Two distinct subtypes of human respiratory syncytial virus.
    J Gen Virol. 1985 Oct;66 ( Pt 10):2111-24 PMID: 2413163
  103. Molecular mechanisms of action of ribavirin.
    Rev Infect Dis. 1990 Nov-Dec;12(6):1139-46 PMID: 2267489
  104. Pathological changes in virus infections of the lower respiratory tract in children.
    J Clin Pathol. 1970 Feb;23(1):7-18 PMID: 4909103
  105. Ribavirin. Ambivalence about an antiviral agent.
    Am J Dis Child. 1988 May;142(5):488-9 PMID: 3358387
  106. In re ribavirin: a case of premature adjudication?
    J Pediatr. 1988 Jan;112(1):154-8 PMID: 3275765
  107. Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome.
    Am J Dis Child. 1985 Nov;139(11):1111-4 PMID: 3877455
  108. Serum complement in acute bronchiolitis.
    Proc Soc Exp Biol Med. 1970 Jun;134(2):499-503 PMID: 4192544
  109. Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus.
    Antimicrob Agents Chemother. 1988 Apr;32(4):589-91 PMID: 3377468
  110. Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection.
    Acta Med Scand. 1967 Sep;182(3):323-30 PMID: 6058359
  111. Prevention of nosocomial respiratory syncytial virus infections through compliance with glove and gown isolation precautions.
    N Engl J Med. 1987 Aug 6;317(6):329-34 PMID: 3600729
  112. Respiratory syncytial virus (RSV) infection rate in personnel caring for children with RSV infections. Routine isolation procedure vs routine procedure supplemented by use of masks and goggles.
    Am J Dis Child. 1987 Jun;141(6):695-7 PMID: 3578197
  113. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.
    Infect Immun. 1984 Feb;43(2):756-8 PMID: 6363300
  114. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults.
    J Clin Microbiol. 1987 Apr;25(4):748-50 PMID: 3571485
  115. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
    Proc Natl Acad Sci U S A. 1986 Dec;83(23):9183-7 PMID: 3097646
  116. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
    J Virol. 1987 Dec;61(12):3855-61 PMID: 3316707
  117. Respiratory syncytial virus infections in adults.
    Am Rev Respir Dis. 1987 Sep;136(3):561-4 PMID: 3631728
  118. Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses.
    Infect Immun. 1981 Apr;32(1):300-3 PMID: 6163726
  119. Respiratory syncytial virus and the infant immune response.
    Arch Dis Child. 1987 Jun;62(6):544-6 PMID: 3619469
  120. The development of respiratory syncytial virus-specific immune complexes in nasopharyngeal secretions following natural infection.
    J Clin Lab Immunol. 1984 Dec;15(4):187-90 PMID: 6527374
  121. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.
    J Virol. 1986 Mar;57(3):721-8 PMID: 2419587
  122. American Academy of Pediatrics Committee on Infectious Diseases: Ribavirin therapy of respiratory syncytial virus.
    Pediatrics. 1987 Mar;79(3):475-8 PMID: 3822659
  123. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.
    J Infect Dis. 1985 Nov;152(5):1083-7 PMID: 4045247
  124. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein.
    Proc Natl Acad Sci U S A. 1985 Jun;82(12):4075-9 PMID: 3858865
  125. Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.
    J Pediatr. 1978 Jul;93(1):28-32 PMID: 206677
  126. IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.
    Arch Dis Child. 1989 Dec;64(12):1661-5 PMID: 2624472
  127. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children.
    J Pediatr. 1973 Apr;82(4):578-90 PMID: 4349062
  128. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells.
    J Gen Virol. 1987 Jun;68 ( Pt 6):1705-14 PMID: 3585282
  129. Neonatal respiratory syncytial virus infection.
    N Engl J Med. 1979 Feb 22;300(8):393-6 PMID: 759915
  130. Nosocomial respiratory syncytial virus infections.
    N Engl J Med. 1975 Dec 25;293(26):1343-6 PMID: 1186836
  131. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.
    J Exp Med. 1988 Sep 1;168(3):1163-8 PMID: 3262705
  132. Interferon in nasal secretions from infants with viral respiratory tract infections.
    J Pediatr. 1978 Jul;93(1):33-6 PMID: 650342
  133. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness.
    J Immunol. 1971 Jul;107(1):123-30 PMID: 5091954
  134. Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.
    J Infect Dis. 1989 Nov;160(5):777-82 PMID: 2809253
  135. Interaction of paramyxoviruses with human basophils and their effect on histamine release.
    J Allergy Clin Immunol. 1989 Oct;84(4 Pt 1):538-46 PMID: 2477431
  136. Ribavirin: a clinical overview.
    Eur J Epidemiol. 1986 Mar;2(1):1-14 PMID: 3021519
  137. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity.
    J Pediatr. 1980 Feb;96(2):179-86 PMID: 6243354
  138. Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus.
    J Med Virol. 1982;9(2):149-58 PMID: 7069409
  139. Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge.
    J Virol. 1986 Nov;60(2):607-13 PMID: 3773052
  140. Control of nosocomial respiratory syncytial viral infections.
    Pediatrics. 1978 Nov;62(5):728-32 PMID: 724317
  141. Aerosolized ribavirin in the treatment of patients with respiratory syncytial virus disease.
    Pediatr Infect Dis J. 1987 Feb;6(2):159-63 PMID: 3550679
  142. Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus.
    J Virol. 1988 Jul;62(7):2228-33 PMID: 3373568
  143. Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity.
    Arch Dis Child. 1989 Dec;64(12):1656-60 PMID: 2624471
  144. Viruses, bacteria, and respiratory disease in children.
    Br Med J. 1960 Apr 9;1(5179):1077-81 PMID: 13826536
  145. Complement activation by respiratory syncytial virus-infected cells.
    Arch Virol. 1986;88(1-2):49-56 PMID: 3954599
  146. Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS).
    Clin Immunol Immunopathol. 1987 Jan;42(1):133-40 PMID: 3491712
  147. Detection of RS-virus IgG-subclass-specific antibodies: variation according to age in infants and small children and diagnostic value in RS-virus-infected small infants.
    J Med Virol. 1985 Aug;16(4):329-35 PMID: 4031829
  148. Speculation on pathogenesis in death from respiratory syncytial virus infection.
    Br Med J. 1970 Feb 7;1(5692):327-30 PMID: 4906701
  149. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease.
    Pediatr Res. 1988 Oct;24(4):504-7 PMID: 3174295
  150. Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.
    Proc Natl Acad Sci U S A. 1986 Mar;83(6):1906-10 PMID: 3513191
  151. Interleukin-1 inhibitor production by human mononuclear leukocytes and leukocyte subpopulations exposed to respiratory syncytial virus: analysis and comparison with the response to influenza virus.
    J Leukoc Biol. 1989 Sep;46(3):189-98 PMID: 2788203
  152. Comparison of three rapid diagnostic techniques for detection of respiratory syncytial virus from nasal wash specimens.
    J Clin Microbiol. 1987 Apr;25(4):746-7 PMID: 3553236
  153. How etiologic, pathologic, and clinical diagnoses can be made in a correlated fashion.
    Pediatr Res. 1977 Mar;11(3 Pt 2):254-61 PMID: 191788
  154. Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection.
    Infect Immun. 1979 Feb;23(2):276-81 PMID: 422241
  155. Respiratory problems 2 years after acute bronchiolitis in infancy.
    Arch Dis Child. 1983 Sep;58(9):713-6 PMID: 6625633
  156. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy.
    Br Med J. 1978 Jan 7;1(6104):11-14 PMID: 620129
  157. Ribavirin: is there a risk to hospital personnel? Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ. 1991 Feb 1;144(3):285-6 PMID: 1989706
  158. A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus.
    Acta Paediatr Scand. 1969 Mar;58(2):116-20 PMID: 4916176
  159. Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection.
    Am J Dis Child. 1977 Feb;131(2):145-8 PMID: 835529
  160. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks.
    J Infect Dis. 1986 Feb;153(2):291-7 PMID: 2418126
  161. Activation of oxidative and arachidonic acid metabolism in neutrophils by respiratory syncytial virus antibody complexes: possible role in disease.
    J Infect Dis. 1983 Jul;148(1):110-6 PMID: 6309990
  162. Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus.
    J Pediatr. 1987 Jan;110(1):87-90 PMID: 3794891
  163. Respiratory virus infections and aeroallergens in acute bronchial asthma.
    Arch Dis Child. 1984 Apr;59(4):310-15 PMID: 6326694
  164. The role of the interferon system in respiratory syncytial virus infections.
    Proc Soc Exp Biol Med. 1971 Dec;138(3):1009-14 PMID: 5131599
  165. Recovery of cytopathogenic agent from chimpanzees with coryza.
    Proc Soc Exp Biol Med. 1956 Jul;92 (3):544-9 PMID: 13359460
  166. Acute bronchiolitis in infancy: treatment and prognosis.
    Thorax. 1989 Jan;44(1):1-5 PMID: 2648640
  167. Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants.
    Clin Exp Immunol. 1986 Jun;64(3):503-9 PMID: 3791688
  168. Management of respiratory failure in infants with acute viral bronchiolitis.
    Am J Dis Child. 1984 Nov;138(11):1071-5 PMID: 6437212
  169. Pathogenesis of respiratory syncytial virus diseases in infancy.
    Arch Dis Child. 1971 Oct;46(249):702-4 PMID: 5118060
  170. Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection.
    Am J Epidemiol. 1973 Sep;98(3):216-25 PMID: 4355005
  171. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters.
    Pediatrics. 1988 Jan;81(1):22-6 PMID: 3336593
  172. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.
    N Engl J Med. 1981 Oct 8;305(15):841-6 PMID: 6168908
  173. The use of eye-nose goggles to control nosocomial respiratory syncytial virus infection.
    JAMA. 1986 Nov 21;256(19):2706-8 PMID: 3773177
  174. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.
    J Pediatr. 1980 May;96(5):808-13 PMID: 7365579
  175. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation.
    J Exp Med. 1986 Apr 1;163(4):1018-23 PMID: 3081678
  176. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy.
    Br Med J (Clin Res Ed). 1982 Jun 5;284(6330):1665-9 PMID: 6805648
  177. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine.
    J Clin Microbiol. 1986 Aug;24(2):197-202 PMID: 3755730
  178. Virus cross-infection in paediatric wards.
    Br Med J. 1973 Jun 9;2(5866):571-5 PMID: 4351623
  179. Epidemic infections caused by respiratory syncytial virus in institutionalized young adults.
    J Infect Dis. 1987 Jun;155(6):1335-9 PMID: 3572045
  180. Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages.
    Infect Immun. 1982 Mar;35(3):1142-6 PMID: 6175576
  181. Acute bronchiolitis: predisposing factors and characterization of infants at risk.
    Pediatr Pulmonol. 1987 May-Jun;3(3):153-60 PMID: 3615038
  182. Apnea associated with respiratory syncytial virus infection in young infants.
    J Pediatr. 1977 Mar;90(3):382-6 PMID: 839330
  183. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.
    Am J Epidemiol. 1973 Oct;98(4):289-300 PMID: 4355170
  184. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children.
    N Engl J Med. 1979 Mar 8;300(10):530-4 PMID: 763253
  185. Maternal antibody and respiratory syncytial virus infection in infancy.
    J Med Virol. 1981;7(4):263-71 PMID: 7038043
  186. HIV envelope glycoprotein, antigen specific T-cell responses, and soluble CD4.
    Lancet. 1990 Apr 7;335(8693):811-5 PMID: 1690832
  187. Biological activities of immunoglobulins of different classes and subclasses.
    Adv Immunol. 1974;19(0):259-94 PMID: 4611173
  188. Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity.
    J Exp Med. 1986 Mar 1;163(3):511-9 PMID: 3485170
  189. Acute Bronchiolitis in Children.
    Br Med J. 1941 Jan 25;1(4177):107-126.1 PMID: 20783494
  190. Arterial blood gas tensions in acute disease of lower respiratory tract in infancy.
    Br Med J. 1963 May 4;1(5339):1192-5 PMID: 13986419
  191. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection.
    J Clin Microbiol. 1986 Aug;24(2):304-6 PMID: 3755731
  192. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection.
    Pediatr Res. 1976 Jan;10(1):75-8 PMID: 1246465
  193. HLA class I antigens in severe RSV bronchiolitis.
    Tissue Antigens. 1989 Sep;34(3):210-2 PMID: 2595727
  194. Activation of complement by cells infected with respiratory syncytial virus.
    Infect Immun. 1981 Jul;33(1):43-8 PMID: 7263071
  195. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection.
    J Pediatr. 1988 Aug;113(2):266-71 PMID: 3397789
  196. Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics.
    Am J Epidemiol. 1973 Nov;98(5):355-64 PMID: 4355632
  197. Early ribavirin treatment of respiratory syncytial viral infection in high-risk children.
    J Pediatr. 1990 Nov;117(5):792-8 PMID: 2231215
  198. Detection of IgE antibodies to bovine respiratory syncytial virus.
    Vet Immunol Immunopathol. 1989 Mar;20(4):313-23 PMID: 2718372
  199. Duration of hospitalization in previously well infants with respiratory syncytial virus infection.
    Pediatr Infect Dis J. 1989 Sep;8(9):601-5 PMID: 2797955
  200. The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection.
    N Engl J Med. 1980 Nov 20;303(21):1198-202 PMID: 7421946
  201. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus.
    Pediatrics. 1971 Nov;48(5):745-55 PMID: 4330595
  202. Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is needed.
    Arch Dis Child. 1988 Aug;63(8):986-90 PMID: 3046516
  203. Receptors for human IgG subclasses on human alveolar macrophages.
    Am Rev Respir Dis. 1984 Mar;129(3):413-8 PMID: 6230972
  204. High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection.
    J Pediatr. 1990 Aug;117(2 Pt 1):313-20 PMID: 2380833
  205. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections.
    J Clin Microbiol. 1987 Aug;25(8):1535-9 PMID: 3305568
Article Info
Journal
European journal of pediatrics
Abbr.
Eur J Pediatr
ISSN
0340-6199
DOI
10.1007/BF01957564
Published
1992-09-00
Pages
638-51
Language
English
Region
Germany
NLM ID
7603873
Subset
IM
External Links
PubMed source DOI: 10.1007/BF01957564 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2